Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
Agenda
09:00 a.m. | Registration |
09:30 a.m. | Introduction Daniel Benitez-Ribas Dept. of Immunology, Hospital Clinic de Barcelona, IDIBAPS, Spain |
09:45 a.m. | Redefining bovine and porcine in vitro models of antigen presenting cells Maria Montoya Centro de Investigaciones Biológicas, CIB-CSIC, Madrid, Spain |
10:15 a.m. | TH1 priming by vaccine dendritic cells depends on IL-12 production by endogenous migratory XCR1+ dendritic cells Manfred Lutz Institute for Virology and Immunobiology, Julius-Maximilian University of Würzburg, Germany |
10:45 a.m. | Autologous tolerogenic dendritic cells for rheumatoid arthritis: the AuToDeCRA study Catharien Hilkens Institute of Cellular Medicine, Newcastle University, UK |
11:15 a.m. | Tumor-derived dendritic cells to slow down tumor growth Damya Laoui Vrije Universiteit Brussel, VIB, Belgium |
11:45 a.m. | Coffee break |
12:15 p.m. | Human pDCs orchestrate the attraction of cytolytic immune effector cells in melanoma DC-vaccination Georgina Flórez Dept. of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands |
12:45 p.m. | Update on monocyte-derived dendritic cell vaccinations to treat leukemia and solid tumors Evelien Smits Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Belgium |
01:15 p.m. | Personalized whole tumor antigen vaccines in ovarian cancer: using tumors for therapy Lana Kandalaft Center of Experimental Therapeutics, Ludwig Institute for Cancer Research, Lausanne, Switzerland |
01:45 p.m. | Discussion |
02:00 p.m. | Refreshments and networking |
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.